NCT03857399View on ClinicalTrials.gov

Empiric Therapy of Patients With Persistent Fever and Agranulocytosis Using Caspofungin

PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 17, 2018

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Fungal Infection
Interventions
DRUG

Caspofungin

Considering the possibility of fungal infection, we take empiric therapy for the patients with persistent fever and agranulocytosis using caspofungin for injection.

Trial Locations (6)

Unknown

Affiliated Concord Hospital of Fujian Medical University, Fuzhou

Jiangsu Province Hospital, Nanjing

The First Affiliated Hospital of Suzhou University, Suzhou

Qilu Hospital of Shandong University, Jinan

Tongji Hospital of Shanghai, Shanghai

The First Affiliated Hospital of Zhejiang University, Hangzhou

All Listed Sponsors
lead

Cttq

INDUSTRY

NCT03857399 - Empiric Therapy of Patients With Persistent Fever and Agranulocytosis Using Caspofungin | Biotech Hunter | Biotech Hunter